Squawk on the Street

Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24

03.26.2024 - By CNBCPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake

CNBC Investing Club Disclaimer

More episodes from Squawk on the Street